Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.4.4 (
adenosine deaminase
)
5,136
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Decreased numbers of natural killer (NK) cells and impaired NK function have been reported in patients with systemic lupus erythematosus (SLE). Since
DAP12
plays a pivotal role in activation of NK cells, we analyzed the expressions of
DAP12
protein and mRNA in peripheral blood NK cells from patients with SLE. Both
DAP12
protein and mRNA expressions in NK cells from the SLE patients were decreased compared with those in NK cells from normal subjects. Sequence analysis of
DAP12
cDNA showed increased nucleotide mutations, including both nucleotide substitutions and deletions. In spite of the mRNA mutations, we found no mutations in genomic DNA, suggesting that mRNA was modified during or after transcription. Decreased expression of
DAP12
in NK cells from the patients was accompanied by increased expression of ADAR1 (
adenosine deaminase
that acts on RNA transcripts) and by decreased expression of NKp44. These results suggest that abnormal expression of
DAP12
molecules in NK cells may account for the impairment of NK cell function in patients with SLE.
...
PMID:Decreased DAP12 expression in natural killer lymphocytes from patients with systemic lupus erythematosus is associated with increased transcript mutations. 1557 31